The Kerraboot® : A novel wound dressing device for the management of leg and foot ulcers

The diabetic foot

Diabetes is reaching epidemic proportions and with it carries the risk of complications. Disease of the foot is among one of the most feared complications of diabetes. The ultimate endpoint of diabetic foot disease is amputation, which is associated with significant morbidity and mortality, besides having immense social, psychological and financial consequences. As the majority of amputations are preceded by foot ulceration, it is crucial to identify those at an increased risk. Diabetic foot ulcers may develop as a result of neuropathy, ischaemia or both and when infection complicates a foot ulcer, the combination can become limb and life threatening. Structural abnormalities such as calluses, bunions, hammer toes, claw toes, flat foot and rocker bottom foot need to be identified and managed.

New, improved Kerraboot: a tool for leg ulcer healing

Lower limb ulcers can be debilitating to the individual affected, and are costly for the NHS to treat. The aim of treatment is to address the underlying pathology that caused the ulcer, and to create a warm, moist wound environment that promotes wound healing, This article discusses the improved Kerraboot, which effectively draws excess moisture away from the wound, but also keeps the wound warm, moist and clean. Although evidence of cost-effectiveness has yet to be collected, anecdotal reports suggest that the device heals wounds quickly and reduces input from health professionals.

The non-pressurised boot dressing: an alternative for use in managing diabetic foot ulceration

A non-pressurised boot dressing keeps wounds moist, warm and humid, stimulating healing and providing a barrier against wound odour. Its use in the management of problematic neuroischaemic diabetic foot ulcers is reported.

Managing leg and foot ulcers: the role of Kerraboot

Foot and leg ulcers are chronic wounds characterized by slow or non-healing breakdown of epidermal and dermal tissue on the foot or below the knee. The prevalence is high and ulcers are a significant drain on the NHS in terms of nursing time and cost of dressings, and are incredibly burdensome to the individual patient. This article reviews the evidence for a new wound management system, Kerraboot, designed for the management of leg and foot ulcers. It is a boot-shaped dressing that completely surrounds the ulcer, creating an optimum healing environment. In clinical investigations, Keraboot offered patients relief from pain, was comfortable, easy to use and effectively controlled embarrassing odour, while also saving nursing time. Currently Kerraboot is recommended for the management of diabetic foot ulcers and venous ulcers where the patient is unable to tolerate compression therapy.